Cleared Traditional

K931520 - EPSTEIN-BARR VIRUS VCA (IGM) RECOMB IMMUN ANTIBODY
(FDA 510(k) Clearance)

Apr 1994
Decision
396d
Days
Class 1
Risk

K931520 is an FDA 510(k) clearance for the EPSTEIN-BARR VIRUS VCA (IGM) RECOMB IMMUN ANTIBODY. This device is classified as a Antibody Igm, If, Epstein-barr Virus (Class I - General Controls, product code LJN).

Submitted by Mrl Diagnostics (Cypress, US). The FDA issued a Cleared decision on April 26, 1994, 396 days after receiving the submission on March 26, 1993.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K931520 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 1993
Decision Date April 26, 1994
Days to Decision 396 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LJN — Antibody Igm, If, Epstein-barr Virus
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235

Similar Devices — LJN Antibody Igm, If, Epstein-barr Virus

All 22
BIOPLEX 2200 EBV IGM KIT
K123021 · Bio-Rad Laboratories · Nov 2012
PLEXUS EBV IGM MULTI-ANALYTE DIAGNOSTICS, MODEL: MP0600M
K073381 · Focus Diagnostics, Inc. · Aug 2008
ATHENA MULTI-LYTE EBV VCA IGM TEST SYSTEM
K042092 · Zeus Scientific, Inc. · Apr 2005
MODIFICATION TO SERAQUEST VCA IGM
K033780 · Quest Intl., Inc. · Jan 2004
SERAQUEST EB VAC IGM
K990977 · Quest Intl., Inc. · Oct 1999
COPALIS EBV-M ANTIBODY ASSAY
K991459 · DiaSorin, Inc. · May 1999